Tesla Motors Inc (TSLA): Top Hedge Funds Bullish on the Company

Tesla Motors Inc (NASDAQ:TSLA), with a market cap of more than $32 billion, has seen its share prices increase more than 72% this year and that has been happening for all the good reasons. The company recently announced its second-quarter scorecard that was encouraging, such as the delivery results which exceeded the company’s outlook.

 Tesla Motors Inc (NASDAQ:TSLA)

Investors also love this stock because of its growth plans that not only include a plan for a manufacturing plant in China, but also what Tesla’s CEO Elon Musk has called a “Gigafactory.” Tesla Motors Inc (NASDAQ:TSLA)’s $5 billion battery plant is expected to solve its battery shortage problem and also lower its operating costs.

Tesla Motors Inc (NASDAQ:TSLA)’s ambitious moves and plans better explain why investors, especially hedge funds, feel comfortable sticking with the stock. Talk about hedge funds and you see Andor Capital Management, led by Daniel Benton, holding 1.25 million shares with a reported value of $300.08 million of Tesla Motors as of the end of the second quarter of 2014. The position remained unchanged from the previous quarter. Another hedge fund bullish on Tesla Motors Inc (NASDAQ:TSLA) is Jat Capital Management, run by John Thaler, which owns 948,778 shares, worth $227.76 million, also unchanged over the quarter.

Another shareholder is Patrick Mccormack’s Tiger Consumer Management, which holds 463,789 shares, valued at $111.34 million up from 402,950 shares held earlier. Tiger consumer is followed by Bridger Management, led by Roberto Mignone, which disclosed ownership of 380,000 shares of Tesla Motors Inc (NASDAQ:TSLA) worth $91.22 million in its latest 13F filing, the stake representing 6.42% of its equity portfolio. The position was slightly increased from 300,000 shares held at the end of the first quarter of 2014.

On the fifth spot is Citadel Investment Group, managed by Ken Griffin, with 237,682 shares with a reported value of $57.06 million as of the end of the second quarter. Citadel has increased its exposure to the company by 195,671 shares over the quarter.

Disclosure: none

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!